Greenoaks
Concentrated long-term venture investor in technology businesses.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Greenoaks Capital Partners, LLC
- Entity type
- COMPANY
- Founded
- 2012
- Headquarters
- 4 Orinda Way, Suite 200, Orinda, CA 94563
- Company size
- 10–49
- Market role
- Private Equity, VC & Investor
- Official website
- greenoaks.com
What Greenoaks does
The firm raises pooled investment vehicles from limited partners and deploys that capital into a concentrated portfolio of private technology and internet-enabled companies. It creates value by sourcing high-conviction investments, supporting portfolio company growth over long holding periods, and realising returns through portfolio appreciation and exits. Its own economics are tied to managing external capital rather than selling software or media.
Category differentiation
Greenoaks is an investment firm, not a software vendor, adtech platform or operating technology company. It should be distinguished from portfolio companies it funds and from unrelated businesses using the Greenoaks name.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Greenoaks Capital Partners, LLC is a private investment firm headquartered in the United States that manages concentrated, long-term venture and growth investments in technology and internet-enabled businesses. The firm operates as an independent fund manager and partners with founders building large-scale software, internet and technology companies. Its customers are institutional limited partners allocating capital to venture and growth funds, and portfolio companies that receive capital and strategic support. Greenoaks generates revenue through fund management economics tied to assets under management, principally management fees and performance-based carried interest. The firm remains active and expanded its capital base with a $2.5 billion sixth venture fund closed in July 2025.
Company news briefing
Briefing updated:
Greenoaks has continued to scale its enterprise and AI portfolio, previously backing Safe Superintelligence alongside a $2 billion round, leading Simile's $200 million Series B at a $2 billion valuation, and supporting AI security startup AIR with a $40 million seed round. The firm also backed Superblocks in securing an AWS partnership for enterprise vibe-coding integration, and joined Altimeter in urging the U.S. Trade Representative to open a Section 301 probe regarding South Korea's regulatory actions toward Coupang.
Business model & monetisation
The firm monetises through investment fund economics: recurring management fees on committed or managed capital and carried interest on realised investment gains. Its commercial model is therefore fund-based rather than transactional, subscription software, advertising, or services-led.
- Fund management fees
- Service Fee
- Carried interest on investment gains
- Percentage Take-Rate
Products & capabilities
No products with linked sources are available in this view.
Subsidiaries & acquisitions
- Coupang
Integrated commerce, logistics and retail media platform.
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Coupang dispute raises U.S. tariff pressure on South Korea
Privacy · Recorded impact score: 3/5
A Republican-led House Judiciary report alleges the South Korean government mounted a targeted campaign against U.S.-headquartered Coupang after a 2025 data breach, prompting calls from some U.S. lawmakers and investors for formal trade investigations and potential tariffs. South Korea disputes the report, defends its actions and the scale of the breach, and says it has engaged with U.S. officials. Investors including Greenoaks and Altimeter urged the U.S. Trade Representative to open a Section 301 probe. The dispute comes amid broader U.S.-South Korea tensions over trade commitments, security cooperation and earlier tariff actions.
- House Judiciary Committee Republicans released a report alleging the South Korean government waged a targeted offensive against Coupang following a data breach.
- South Korea levied a 625 billion won (about $409 million) data-privacy fine on Coupang; Seoul says the breach affected 37.55 million people.
Simile AI: Behavioral Simulation and Scaling Laws
Behavioral simulation and synthetic populations for decision-making · Recorded impact score: 4/5
This podcast episode with Simile co-founder and CEO Joon Sung Park explores the company’s work building behavioral foundation models and synthetic populations for simulation. The discussion covers Simile’s methodology (interviews, transaction/observational data, randomized controlled trials, and post-training on causal mechanisms), validated research (a 1,000-person study where digital twins reproduced human behavior ~85% as accurately as the original humans), enterprise use cases (tens of millions of simulations for Fortune 100 clients like CVS), and the broader ambition to scale multi-agent simulations toward society-scale models. The episode also mentions Simile’s recent Series B at a $2B valuation and funding/backers reported in coverage.
- Simile AI is reported to have a Series B at a $2 billion valuation.
- Simile runs tens of millions of simulations for enterprise customers, including Fortune 100 clients like CVS.
Simile Raises $200M Series B at $2B Valuation
Fundraising · Recorded impact score: 2/5
Simile, a startup that builds synthetic/simulated users for marketing and product research, raised $200 million in a Series B at a $2 billion valuation. The round, announced July 30, 2026, was led by Greenoaks with participation from Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory, Definition and CVS Health Ventures. The raise comes five months after Simile's $100 million Series A led by Index. Simile was founded by Joon Sung Park and counts CVS among its customers. The company positions its technology as a way to simulate user behavior for research and product testing, attracting growing VC interest in the synthetic-user market.
- Simile closed a $200 million Series B at a $2 billion valuation (announced 2026-07-30).
- The Series B was led by Greenoaks with participation from Index, Hanabi, Bain Capital Ventures, A*, Factory, Definition and CVS Health Ventures.
Explore company relationships
Questions about Greenoaks
What is Greenoaks?
Greenoaks is a private venture and growth investment firm focused on concentrated, long-term investments in technology and internet-enabled businesses.
Who uses Greenoaks?
Its direct customers are institutional limited partners investing in its funds, while founders and management teams use Greenoaks as a long-term capital partner.
How does Greenoaks make money?
Greenoaks makes money through fund management fees and carried interest earned on successful investment outcomes.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
13 publicly documented primary sources and citations linked across the market graph.
Continue your research on Greenoaks
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.